As a part of concerted mechanisms that occur in the TME, a multitude of cancer cells constitutively express or upregulate IDO1, TDO2, or both, and coerce stromal and tumor-infiltrating immune cells to express IDO1, supporting evasion of immunosurveillance (11, 26–30). The gene discussed is TDO2; the disease is neoplasm.